10.02.2010 • NewsCelaneseportfolioprofits

Celanese Profit Beats Street; Revenue Up 8%

Celanese posted a better-than-expected fourth-quarter profit as demand for its chemical products increased, pushing revenue higher. The company reported net income of $5 million, or 2 cents per share, compared with a year-earlier loss of $155 million, or $1.09 per share.

Excluding one-time items, including restructuring charges, Celanese posted profit of 50 cents per share. Analysts expected earnings of 47 cents per share, according to Thomson Reuters I/B/E/S. Revenue rose 8 percent to $1.39 billion. Analysts expected $1.25 billion.

Company

Celanese

Brüningstr.
Frankfurt
Germany

Company contact







Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.